| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.33 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.57 | 0.03 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.36 | 0.04 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |